Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel Trk-A inhibitors designed by Merck & Co.

Dec. 16, 2013

Mallinckrodt completes clinical trials of MNK-155

Dec. 16, 2013

Convergence Pharmaceuticals prepares novel sodium channel blockers for pain

Dec. 16, 2013

Roche and Prothena collaborate on antibodies for Parkinson's disease

Dec. 13, 2013

Abstral launched in Japan

Dec. 13, 2013

Avanir releases results from phase II PRIME study

Dec. 13, 2013

Scientists at Convergence Pharmaceuticals synthesize new Na(v)1.7 blockers

Dec. 12, 2013

Orion Corp. synthesizes new series of COMT inhibitors

Dec. 12, 2013

French researchers disclose novel mGlu2 receptor modulators

Dec. 12, 2013

Lundbeck and Otsuka set to codevelop Alzheimer's disease vaccine

Dec. 12, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...